LEAP-012 trial in progress: Transarterial chemoembolization (TACE) with or without lenvatinib plus pembrolizumab for intermediate-stage hepatocellular carcinoma (HCC)

被引：4
|
作者：
El-Khoueiry, Anthony B.
Llovet, Josep M.
Vogel, Arndt
Madoff, David C.
Finn, Richard S.
Ogasawara, Sadahisa
Ren, Zhenggang
Mody, Kalgi
Li, Jerry J.
Siegel, Abby B.
Dubrovsky, Leonid
Kudo, Masatoshi
机构：
[1] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
[2] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA
[3] Univ Barcelona, Hosp Clin Barcelona, IDIBAPS, Catalonia, Spain
[4] Inst Catalana dEstudis Avancats ICREA, Barcelona, Spain
[5] Hannover Med Sch, Hannover, Germany
[6] Smilow Canc Hosp, Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[7] Smilow Canc Hosp, Yale New Haven Hlth, New Haven, CT USA
[8] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[9] Chiba Univ, Grad Sch Med, Chiba, Japan
[10] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[11] NJ Merck Co Inc, Woodcliff Lake, Kenilworth, NJ USA
[12] Kindai Univ, Sch Med, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.TPS494
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS494
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Overall survival in intermediate-stage hepatocellular carcinoma (HCC) patients after first transarterial chemoembolization (TACE): Proposal of a new scoring system.
    Sacco, Rodolfo
    Mismas, Valeria
    Romano, Antonio
    Ginanni, Barbara
    Marceglia, Sara
    Giacomelli, Luca
    Masi, Gianluca
    Falcone, Alfredo
    Bresci, Giampaolo
    Bartolozzi, Carlo
    Bargellini, Irene
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [22] Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients
    Caihua Zhu
    Bing Dai
    Hua Zhan
    Ruoyu Deng
    Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1065 - 1071
  • [23] Neoadjuvant transarterial chemoembolization (TACE) plus PD-1 inhibitor bridging to tumor resection in intermediate-stage hepatocellular carcinoma patients
    Zhu, Caihua
    Dai, Bing
    Zhan, Hua
    Deng, Ruoyu
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1065 - 1071
  • [24] Trial Results for Sunitinib and Transarterial Chemoembolization (TACE) in Inoperable Hepatocellular Carcinoma (HCC)
    Wu, Y. V.
    Tomaszewski, G. M.
    Fetterly, G. J.
    Kuvshinoff, B.
    Groman, A.
    Wilkinson, N. W.
    Khushalani, N. I.
    Iyer, R. V.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S114 - S115
  • [25] Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate-stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
    Zheng, Yitao
    Xiang, Yanjun
    Shi, Hongqi
    Lin, Zhuoqun
    Cheng, Shuqun
    Zhu, Jiuting
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1079 - 1093
  • [26] Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
    Kim, Jun Young
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Choi, Gyu-Seong
    Saleh, Aldosri Meshal
    Joh, Jae-Won
    Cho, Sung Ki
    Shin, Sung Wook
    Carriere, Keumhee Chough
    Ahn, Joong Hyun
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (02) : 250 - 258
  • [27] Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma
    Chen, Shuling
    Jin, Huilin
    Dai, Zihao
    Wei, Mengchao
    Xiao, Han
    Su, Tianhong
    Li, Bin
    Liu, Xin
    Wang, Yu
    Li, Jiaping
    Shen, Shunli
    Zhou, Qi
    Peng, Baogang
    Peng, Zhenwei
    Peng, Sui
    CANCER MEDICINE, 2019, 8 (04): : 1530 - 1539
  • [28] New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization
    Kim, Jin Hyoung
    Shim, Ju Hyun
    Lee, Han Chu
    Sung, Kyu-Bo
    Ko, Heung-Kyu
    Ko, Gi-young
    Gwon, Dong Il
    Kim, Jong Woo
    Lim, Yung-Suk
    Park, Seong Ho
    LIVER INTERNATIONAL, 2017, 37 (12) : 1861 - 1868
  • [29] Hepatic resection is superior to transarterial chemoembolization for treating intermediate-stage hepatocellular carcinoma
    Zhong, Jian-Hong
    Peng, Ning-Fu
    You, Xue-Mei
    Ma, Liang
    Li, Le-Qun
    LIVER INTERNATIONAL, 2017, 37 (07) : 1083 - 1084
  • [30] A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Azemoto, Ryosaku
    Shinozaki, Masami
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    PLOS ONE, 2015, 10 (04):
12345